Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback